abstract |
In particular, generally in accordance with Formula 1a: (Ia) (wherein E and R1-11 have the meanings described herein) according to Formula 1a: (Ia) Compounds; prodrugs and pharmaceutically acceptable salts thereof are provided. Other formulas and methods of use are also provided. [Chemical 1] [Selection figure] None |